Lumos Pharma, Inc.

Historical 13F Holders

Symbol
LUMO
CUSIP
55028X109
All holders as of
Q3 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 55028X109 since 12/18/2024, largest first.

Filer % of Class Filed
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Wells Fargo & Company/MN 13G/A 0.8% 10/25/2024
Event 9/30/2024
Goldman Sachs Group Inc 13G/A
0% 2/13/2025
Event 12/31/2024
Private Advisor Group, LLC 13G/A 0% 2/13/2025
Event 12/31/2024

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2024 Q3 30 2.09 M $8.08M
2024 Q2 38 2.08 M $4.82M
2024 Q1 38 2.18 M $6.14M
2023 Q4 38 2.37 M $7.52M
2023 Q3 36 2.44 M $8.05M
2023 Q2 37 2.39 M $7.90M
2023 Q1 39 2.23 M $7.40M
2022 Q4 41 2.41 M $9.24M
2022 Q3 37 2.56 M $23.0M
2022 Q2 39 2.39 M $18.7M
2022 Q1 38 2.48 M $23.3M
2021 Q4 40 2.70 M $18.7M
2021 Q3 38 2.87 M $27.3M
2021 Q2 42 3.20 M $32.1M
2021 Q1 43 3.32 M $38.8M
2020 Q4 49 3.77 M $135M
2020 Q3 39 3.64 M $50.2M
2020 Q2 45 3.56 M $58.7M
2020 Q1 47 3.28 M $27.9M